Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

EVP, Res. & Preclin. Dev.

SVP, Chem. Mfg & Controls

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. Its lead product candidate is PGN-EDO51, an EDO peptide that id in Phase I clinical trial to treat individuals with Duchenne muscular dystrophy (DMD). The company is also developing PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 1 clinical trial for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. PepGen Inc. was founded in 2018 and is headquartered in Boston, Massachusetts.

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment o...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-09	Premium	bought	Premium	Premium	Premium	-
2023-11-30	Premium	bought	Premium	Premium	Premium	President and CEO
2023-06-08	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-08	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-07	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-06	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-06	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-05	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-05	Premium	sold	Premium	Premium	Premium	President and CEO
2023-06-02	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-06-02	Premium	sold	Premium	Premium	Premium	President and CEO
2023-03-24	Premium	sold	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-03-24	Premium	acquired	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-08	Premium	sold	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-08	Premium	acquired	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-07	Premium	sold	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-07	Premium	acquired	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-06	Premium	acquired	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2023-02-06	Premium	sold	Premium	Premium	Premium	EVP, Res. & Preclin. Dev.
2022-12-19	Premium	acquired	Premium	Premium	Premium	SVP, Chem. Mfg & Controls
2022-05-10	Premium	bought	Premium	Premium	Premium	-
2022-05-10	Premium	bought	Premium	Premium	Premium	-
2022-05-10	Premium	acquired	Premium	Premium	Premium	-
2022-05-10	Premium	acquired	Premium	Premium	Premium	-

PEPG - PepGen Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for PEPG